ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 3 04:53 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Mar 4 03:08 ET
ANTENGENE-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Feb 26 03:35 ET
ANTENGENE-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Feb 26 03:30 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Feb 1 03:25 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Jan 4 03:25 ET
ANTENGENE-B: VOLUNTARY ANNOUNCEMENT SELINEXOR (XPOVIO), ANTENGENE''S FIRST-IN-CLASS NEW DRUG, SUCCESSFULLY INCLUDED IN 2023 NATIONAL REIMBURSEMENT DRUG LIST
Dec 13, 2023 17:50 ET
ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF MACAU FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Dec 6, 2023 03:30 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Dec 5, 2023 03:25 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Nov 3, 2023 04:25 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Oct 5, 2023 04:25 ET
ANTENGENE-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS
Sep 27, 2023 04:54 ET
ANTENGENE-B: VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENT
Sep 17, 2023 20:08 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Sep 5, 2023 05:51 ET
ANTENGENE-B: INSIDE INFORMATION COLLABORATION AGREEMENT BETWEEN ANTENGENE AND HANSOH PHARMA FOR THE COMMERCIALIZATION OF XPOVIO (SELINEXOR) IN THE MAINLAND OF CHINA
Aug 10, 2023 20:00 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Aug 3, 2023 04:25 ET
ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE HONG KONG DEPARTMENT OF HEALTH FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA
Jul 16, 2023 19:52 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Jul 6, 2023 04:24 ET
ANTENGENE-B: SEVENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Jun 16, 2023 07:00 ET
ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Jun 6, 2023 04:25 ET
No Data
No Data